Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes

摘要

The systematic review by Laforest et al is a timely addition to understand the challenges that expanding genetic risk assessment and into primary care pose.1 This is especially opportune given its online publication in the same week that the Secretary of State Matt Hancock announced the plan for the NHS to offer genomic testing to healthy individuals for a fee.2Direct-to-consumer genetic testing is already available. Companies such as 23andme (https://www.23andme.com/en-gb/dna-health-ancestry/#all-reports-list) will give …